BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
92.23
-1.43 (-1.53%)
At close: May 13, 2026, 4:00 PM EDT
92.65
+0.42 (0.46%)
After-hours: May 13, 2026, 7:13 PM EDT
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of $23.32 billion as of May 13, 2026. Its market cap has decreased by -6.55% in one year.
Market Cap
23.32B
Enterprise Value
7.87B
1-Year Change
-6.55%
Ranking
Category
Stock Price
$92.23
Market Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $23.32B, an increase of 678.75%. That is a compound annual growth rate of 36.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 23.32B | 1.89% |
| Dec 31, 2025 | 22.89B | -16.21% |
| Dec 31, 2024 | 27.32B | 8.89% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alnylam Pharmaceuticals | 38.03B |
| BeOne Medicines AG | 34.55B |
| Revolution Medicines | 30.65B |
| Royalty Pharma | 29.74B |
| Insmed | 22.52B |
| Moderna | 20.98B |
| Roivant Sciences | 20.73B |
| Incyte | 20.04B |